Replies to post #431001 on Amarin Corp Plc (AMRN)

[Number sleven]

One, I don't think we should start with the assumption that the company is for sale. The company needs to be profitable. If management was preparing the company for a near term sale, they wouldn't be building a European sales structure. I also doubt they would be entering into this many partnerships. What I see is a company trying to become profitable. Once that happens the share buyback makes sense. Sales in Europe are improving. It isn't fast, but margins are good. You can't effectively negotiate from a position of weakness. We have had two separate management teams that have both apparently decided that this course will be successful. I agree with them.
Sleven,

[JRoon71]

Onerag, one point of clarification on costs. I don't think Amarin breaks out operating costs by geography/location, so ALL worldwide operating costs flow through the main P&L. They may break them out internally (I am certain they do), but for public financial statements, every single employee and cost of Amarin is represented on the SG&A or R&D line (for the scientific folks). And we have a lot of teams around the world rolling out Vazkepa.

In the case of Hikma, their division budgets do not include the corporate overhead (CEO, CFO, CMO, HR, home office, etc.).

So, you cannot compare Amarin's entire budget to some company's single division budget. It's apples to oranges.

I will give Sarissa credit, they have don a good job of controlling spending.